Weijun Shen

15PUBLICATIONS
43CO-AUTHORS
Molecular targetsInnate immunityPharmacogenomicsPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 22, 2025
Cell-based high-throughput screening using a target-NanoLuc fusion construct to identify molecular glue degraders of c-Myc oncoprotein.

Muyu Xu, Jinying Qiu, Lin Tan

|Mar 26, 2024
A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis.

Ryan Watkins, Ana Gamo, Seung Hyuk Choi

|Apr 17, 2023
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants.

Yubin Liu, Ziyi Wang, Xinyu Zhuang

|Apr 13, 2022
Design of Potent and Proteolytically Stable Biaryl-Stapled GLP-1R/GIPR Peptide Dual Agonists.

Yifang Yang, Candy Lee, Reddy Rajasekhar Reddy

|Sep 10, 2021
α/Sulfono-γ-AApeptide Hybrid Analogues of Glucagon with Enhanced Stability and Prolonged In Vivo Activity.

Peng Sang, Hongxiang Zeng, Candy Lee

|Aug 27, 2020
Engineering of a Potent, Long-Acting NPY2R Agonist for Combination with a GLP-1R Agonist as a Multi-Hormonal Treatment for Obesity.

Sam Lear, Elsa Pflimlin, Zhihong Zhou

Pageof 3

Frequent Collaborators

4 joint publications

Peter G Schultz

3 joint publications

Pengyu Yang

2 joint publications

Yahu A Liu

2 joint publications

Valentina Molteni